Back to today’s briefing

Story perspectives

Merck Acquires Verona Pharma for $10 Billion Boost

7/12/2025

33 3

Summary

Story summary

Merck is set to make waves in the pharmaceutical world by acquiring London-based Verona Pharma for around $10 billion. This strategic move centers on Ohtuvayre, a groundbreaking COPD treatment recently approved by the FDA. With this acquisition, Merck aims to expand its cardio-pulmonary offerings and bring vital relief to patients while boosting shareholder value.

1 of 1

Story summary

Merck is set to make waves in the pharmaceutical world by acquiring London-based Verona Pharma for around $10 billion. This strategic move centers on Ohtuvayre, a groundbreaking COPD treatment recently approved by the FDA. With this acquisition, Merck aims to expand its cardio-pulmonary offerings and bring vital relief to patients while boosting shareholder value.